Cite
MLA Citation
Andrew J Pollard et al.. “Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.” Lancet infectious diseases, vol. 21, no. 4, 2021, pp. 493–506. http://access.bl.uk/ark:/81055/vdc_100124043475.0x00001f